EZH2 and neoplasm: We may be inspired by studies that have achieved some results, such as combining EZH2 inhibitors with immunotherapy, chemotherapy, targeted therapy, endocrine therapy, and other therapies that may achieve complementary or synergistic anti-tumor effects [115].